Polymer microneedles for controlled-release drug delivery.

Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.
Pharmaceutical Research (Impact Factor: 3.95). 05/2006; 23(5):1008-19. DOI: 10.1007/s11095-006-0028-9
Source: PubMed

ABSTRACT As an alternative to hypodermic injection or implantation of controlled-release systems, this study designed and evaluated biodegradable polymer microneedles that encapsulate drug for controlled release in skin and are suitable for self-administration by patients.
Arrays of microneedles were fabricated out of poly-lactide-co-glycolide using a mold-based technique to encapsulate model drugs--calcein and bovine serum albumin (BSA)--either as a single encapsulation within the needle matrix or as a double encapsulation, by first encapsulating the drug within carboxymethylcellulose or poly-L: -lactide microparticles and then encapsulating drug-loaded microparticles within needles.
By measuring failure force over a range of conditions, poly-lactide-co-glycolide microneedles were shown to exhibit sufficient mechanical strength to insert into human skin. Microneedles were also shown to encapsulate drug at mass fractions up to 10% and to release encapsulated compounds within human cadaver skin. In vitro release of calcein and BSA from three different encapsulation formulations was measured over time and was shown to be controlled by the encapsulation method to achieve release kinetics ranging from hours to months. Release was modeled using the Higuchi equation with good agreement (r2 > or = 0.90). After microneedle fabrication at elevated temperature, up to 90% of encapsulated BSA remained in its native state, as determined by measuring effects on primary, secondary, and tertiary protein structure.
Biodegradable polymer microneedles can encapsulate drug to provide controlled-release delivery in skin for hours to months.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Transdermal delivery has become a popular route of drug delivery in recent years. However, permeation of drugs through skin is limited to small lipophilic molecules. Microneedle technology involves the creation of micron-sized channels in the skin, which can allow the delivery of hydrophilic molecules including large proteins which do not pass the skin barrier passively. Microneedles can be manufactured in different geometries from various materials such as silicon, glass, sugars and polymers and this technology has been shown to effectively increase the permeation rates of a wide range of therapeutic compounds, including proteins, in several studies on animal models and humans. Combination with other techniques such as iontophoresis and sonophoresis may result in synergistic effects. New products involving microneedle technology are currently being developed in the industry and the prospects are highly promising.
    Journal of Drug Delivery Science and Technology 01/2009; 19(5):303-310. DOI:10.1016/S1773-2247(09)50065-2 · 1.09 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Microneedles are developed in order to become the transdermal administration method of the future. They however still face numerous challenges. This paper addresses the challenge to effectively insert the microneedle arrays into membranes. A recently proposed model membrane and test method for microneedles insertion, published in International Journal of Pharmaceutics, is used in this aim. A moulded 4x4 hollow polymer microneedle array developed at the Université Libre de Bruxelles is tested for insertion using this model. Results show that the array is extremely resistant to insertion, it can withstand very high forces and even multiple insertions without blunting. Different insertion tests were performed on a folded in eight Parafilm® film because it exhibits excellent similarity to porcine skin. The insertion force, the insertion speed and the holding time of the array against membranes must be optimised in order to get efficient reliable insertions at, at least, 500μm depth. Copyright © 2015. Published by Elsevier B.V.
    International Journal of Pharmaceutics 01/2015; DOI:10.1016/j.ijpharm.2015.01.019 · 3.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The paper presents a review on transdermal drug delivery using mechanical enhancer – microneedles. The paper overviews the delivery mechanism, the main delivery methods utilizing the microneedle array, the frequently used materials for the fabrication process, geometrical and shape considerations as well as the current pre-clinical and clinical applications of the microneedles array. Finally, we express our point of view regarding the perspectives in the field of transdermal drug delivery using mechanical enhancer.


Available from